Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

M. Reck; M.C. Garassino; M. Imbimbo; F.A. Shepherd; M.A. Socinski; J.-Y. Shih; A. Tsao; P. Lee; K.B. Winfree; A. Sashegyi; R. Cheng; R. Varea; B. Levy; E. Garon

doi:10.1016/j.lungcan.2018.03.025

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

M. Reck, M.C. Garassino, M. Imbimbo, F.A. Shepherd, M.A. Socinski, J.-Y. Shih, A. Tsao, P. Lee, K.B. Winfree, A. Sashegyi, R. Cheng, R. Varea, B. Levy, E. Garon

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	62-69
Number of pages	8
Journal	Lung Cancer
Volume	120
DOIs	https://doi.org/10.1016/j.lungcan.2018.03.025
Publication status	Published - 2018

Access to Document

10.1016/j.lungcan.2018.03.025

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044959258&doi=10.1016%2fj.lungcan.2018.03.025&partnerID=40&md5=e49209a5e107d785f4b7a9edffec37fa

Cite this

Reck, M., Garassino, M. C., Imbimbo, M., Shepherd, F. A., Socinski, M. A., Shih, J-Y., Tsao, A., Lee, P., Winfree, K. B., Sashegyi, A., Cheng, R., Varea, R., Levy, B., & Garon, E. (2018). Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting. Lung Cancer, 120, 62-69. https://doi.org/10.1016/j.lungcan.2018.03.025

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting. / Reck, M.; Garassino, M.C.; Imbimbo, M.; Shepherd, F.A.; Socinski, M.A.; Shih, J.-Y.; Tsao, A.; Lee, P.; Winfree, K.B.; Sashegyi, A.; Cheng, R.; Varea, R.; Levy, B.; Garon, E.

In: Lung Cancer, Vol. 120, 2018, p. 62-69.

Research output: Contribution to journal › Article › peer-review

Reck, M, Garassino, MC, Imbimbo, M, Shepherd, FA, Socinski, MA, Shih, J-Y, Tsao, A, Lee, P, Winfree, KB, Sashegyi, A, Cheng, R, Varea, R, Levy, B & Garon, E 2018, 'Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting', Lung Cancer, vol. 120, pp. 62-69. https://doi.org/10.1016/j.lungcan.2018.03.025

@article{9c983aaf28374aae976ccb649259f2ea,

title = "Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting",

author = "M. Reck and M.C. Garassino and M. Imbimbo and F.A. Shepherd and M.A. Socinski and J.-Y. Shih and A. Tsao and P. Lee and K.B. Winfree and A. Sashegyi and R. Cheng and R. Varea and B. Levy and E. Garon",

note = "cited By 5",

year = "2018",

doi = "10.1016/j.lungcan.2018.03.025",

language = "Non definita",

volume = "120",

pages = "62--69",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

AU - Reck, M.

AU - Garassino, M.C.

AU - Imbimbo, M.

AU - Shepherd, F.A.

AU - Socinski, M.A.

AU - Shih, J.-Y.

AU - Tsao, A.

AU - Lee, P.

AU - Winfree, K.B.

AU - Sashegyi, A.

AU - Cheng, R.

AU - Varea, R.

AU - Levy, B.

AU - Garon, E.

N1 - cited By 5

PY - 2018

Y1 - 2018

U2 - 10.1016/j.lungcan.2018.03.025

DO - 10.1016/j.lungcan.2018.03.025

M3 - Articolo

VL - 120

SP - 62

EP - 69

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -